Human-derived bacterial strains mitigate colitis via modulating gut microbiota and repairing intestinal barrier function in mice - Dai, Juanjuan; Jiang, Mingjie; Wang, Xiaoxin; Lang, Tao; Wan, Leilei; Wang, Jingjing (BMC microbiology, 2024)
Keywords: Acetic acid; Animals; Antibiotics; Bacteria; Bacteroidetes; Care and treatment; Cecum; Colitis; Colitis - chemically induced; Colitis, Ulcerative - chemically induced; Colitis, Ulcerative - therapy; Colon; Composition; Cytokines; Development and progression; Dextran; Dextran sulfate; Dextrans; Digestive system; Disease Models, Animal; E coli; Enterococcus faecium; Escherichia coli; Feces; G protein-coupled receptors; Gastrointestinal Microbiome; Gastrointestinal tract; Gene expression; Gene sequencing; Gut barrier dysfunction; Gut microbiota; Health aspects; Host-bacteria relationships; Human-derived strain; Humans; Inflammation; Inflammatory bowel disease; Inflammatory bowel diseases; Intestinal Barrier Function; Intestinal microflora; Intestine; Metabolites; Mice; Mice, Inbred C57BL; Microbiota; Microbiota (Symbiotic organisms); Microorganisms; Pathogenesis; Patients; Pharmaceuticals; Probiotics; Receptors; Remission; Remission (Medicine); RNA, Ribosomal, 16S - genetics; rRNA 16S; Short chain fatty acids; Strains (organisms); Ulcerative colitis; China; Gut microbiota; Gut barrier dysfunction; Colitis; Human-derived strain; Short chain fatty acids